- Abbott Laboratories press release (ABT): Q4 Non-GAAP EPS of $1.50 beats by $0.01.
- Revenue of $11.46B (+4.5% Y/Y) misses by $340M.
- Abbott projects full-year 2026 adjusted diluted EPS of $5.55 to $5.80, which reflects 10 percent growth at the midpoint
- Shares -1.4% PM.
Abbott Laboratories Non-GAAP EPS of $1.50 beats by $0.01, revenue of $11.46B misses by $340M
